Senior insider sale
Senior VP, R&D at REPLIGEN CORP — senior position signals high conviction
$739.7K
4.46K shares
What this filing means
KURIYEL RALF plans to sell 4.46K shares of REPLIGEN CORP valued at approximately $739.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/1/2024ACC: 0001969223-24-000552
4.46K
Shares to sell
$739.7K
Approx. market value
4.46K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
PSUM Vesting
NA
2/28/2022
2.65KRSU Vesting
NA
12/14/2021
440.00RSU Vesting
NA
3/1/2021
1.38KTotal acquired4.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2022 | PSUM Vesting NA | 2.65K | — |
12/14/2021 | RSU Vesting NA | 440.00 | — |
3/1/2021 | RSU Vesting NA | 1.38K | — |
| Total | 4.46K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.46K
Market value
$739.7K
8/1/2024
Total
Units
4.46K
Value
$739.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/1/2024 | 4.46K | $739.7K | NASDAQ | Planned |
| Total | 4.46K | $739.7K | ||